World-renowned expert in psychopharmacology, addiction, and mental health treatments joins the fast-growing neuroscience company to help advance pioneering therapeutics BOSTON, Oct. 25, 2021 /PRNewswire/ — Delix Therapeutics (the “Company”), a neuroscience company developing novel disease-modifying therapeutics for serious psychiatric and neurological conditions, today announced the appointment of…
